(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 140.52% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 106.08%, and it is also forecast to beat the US market's average forecast revenue growth rate of 24.88%.
Ideaya Biosciences's revenue in 2025 is $7,000,000.On average, 20 Wall Street analysts forecast IDYA's revenue for 2025 to be $1,166,712,748, with the lowest IDYA revenue forecast at $0, and the highest IDYA revenue forecast at $2,852,801,979. On average, 20 Wall Street analysts forecast IDYA's revenue for 2026 to be $3,726,697,172, with the lowest IDYA revenue forecast at $0, and the highest IDYA revenue forecast at $15,455,964,026.
In 2027, IDYA is forecast to generate $9,065,862,880 in revenue, with the lowest revenue forecast at $2,233,161,119 and the highest revenue forecast at $17,335,921,091.